GlySens Incorporated is a privately held corporation that is committed to developing a long term glucose sensor system to continuously monitor glucose levels and enhance the care and treatment of diabetes.

The GlySens approach employs a long term, fully implanted sensor that is unobtrusive and functions automatically and continuously, transmitting its signal to an external monitor. The system is intended to provide a significantly improved lifestyle for people living with diabetes. The Company's unique position in the field is built upon a solid foundation of scientific and engineering achievements, and a team of dedicated managers, scientists, engineers, and support staff with a demonstrated record of success in the development and introduction of new technologies for continuous glucose monitoring.